Sage Therapeutics Inc (SAGE) with a beta value of 0.91 appears to be a promising investment opportunity.
Sage Therapeutics Inc (NASDAQ: SAGE) kicked off on Friday, down -5.13% from the previous trading day, before settling in for the closing price of $5.85.